摘要:
A living plant can function as self-powered auto-samplers and preconcentrators of an analyte within ambient groundwater, detectors of the analyte contained therein. For example, a pair of near infrared (IR) fluorescent sensors embedded within the mesophyll of the plant leaf can be used as detectors of the nitroaromatic molecules, with the first IR channel engineered through CoPhMoRe to recognize analyte via an IR fluorescent emission and the second IR channel including a functionalized nanostructure that acts as an invariant reference signal.
摘要:
The present invention relates to methods for detecting, diagnosing and/or treating endometrial cancer by detecting in a biological sample from a patient the levels of one or more of the metabolites: C14.2, PC ae C38:1, 3-Hydroxybutyric acid, C18:2, PC ae C40:1, and C6 (C4:1-DC). In some embodiments, the method also includes diagnosing the patient with endometrial cancer when the one or more metabolites in the biological sample is at a different level than a statistically validated threshold for the one or more metabolites, and ultrasound indicates endometrial cancer in the patient. In further embodiments, once endometrial cancer is diagnosed, the patient is treated for the endometrial cancer.
摘要:
The present disclosure relates to biosensors, kits and methods for detecting and/or quantifying lysophosphatidic acid (LPA) in a liquid sample such as a serum sample from a subject. The present disclosure also relates to linker compounds that are useful, for example, in the biosensors, kits and methods of the present disclosure and to methods for preparing a biosensor for detecting and/or quantifying lysophosphatidic acid (LPA) in a liquid sample.
摘要:
A method of ion imaging is disclosed that includes automatically sampling a plurality of different locations on a sample (20) using a first device (21) which is arranged and adapted to generate aerosol, smoke or vapour from the sample (20). Mass spectral data and/or ion mobility data corresponding to each location is obtained and the obtained mass spectral data and/or ion mobility data is used to construct, train or improve a sample classification model.
摘要:
A method of analysis using mass spectrometry and/or ion mobility spectrometry is disclosed. The method comprises: using a first device to generate smoke, aerosol or vapour from a target comprising or consisting of a microbial population; mass analysing and/or ion mobility analysing said smoke, aerosol or vapour, or ions derived therefrom, in order to obtain spectrometric data; and analysing said spectrometric data in order to analyse said microbial population.
摘要:
A method of analysis using mass spectrometry and/or ion mobility spectrometry is disclosed comprising: (a) using a first device to generate smoke, aerosol or vapour from a target in vitro or ex vivo cell population; (b) mass analysing and/or ion mobility analysing said smoke, aerosol or vapour, or ions derived therefrom, in order to obtain spectrometric data; and (c) analysing said spectrometric data in order to identify and/or characterise said target cell population or one or more cells and/or compounds present in said target cell population.
摘要:
A method is disclosed comprising obtaining physical or other non-mass spectrometric data from one or more regions of a target using a probe (20). The physical or other non-mass spectrometric data may be used to determine one or more regions of interest of the target. An ambient ionisation ion source (1) may then used to generate an aerosol, smoke or vapour (5) from one or more regions of the target.
摘要:
The invention relates to a method of diagnosing and treating hepatitis virus infection, such as hepatitis B or C virus infection, or a disease mediated by hepatitis infection, such as hepatitis B or C virus infection, by using the autotaxin-lysophosphatidic acid signalling pathway. The invention also relates to biomarkers for hepatitis infection, such as hepatitis B or C virus infection, or a disease mediated by hepatitis infection, such as hepatitis B or C virus infection.
摘要:
The disclosure provides methods for detecting and diagnosing diseases and conditions associated with defects in cardiolipin remodeling. In some embodiments, the present technology relates to methods for detecting the presence or amount of cardiolipin isoforms and/or the presence or amount of enzymes involved in cardiolipin remodeling.
摘要:
Exemplary embodiments of the present disclosure relate to CO 2 -based chromatography for the efficient and precise separation of fatty acids. The present disclosure is based, in part, on the discovery that a CO 2 -based chromatography system with features, such as, e.g., improved pressure stability, improved sample injection, and superior column packing materials, reproducibly resolve fatty acids.